Matthew Hung1, Erik Ortmann1, Martin Besser2, Pedro Martin-Cabrera2, Toby Richards3, Marcus Ghosh1, Fiona Bottrill4, Timothy Collier5, Andrew A Klein1. 1. Department of Anaesthesia, Papworth Hospital, Cambridge, UK. 2. Department of Haematology, Addenbrookes Hospital, Cambridge, UK. 3. Division of Surgery and Interventional Science, University College London, London, UK. 4. Department of Research and Development, Papworth Hospital, Cambridge, UK. 5. Department of Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Abstract
OBJECTIVES: Preoperative anaemia is associated with increased morbidity and mortality. We sought to determine the relative frequencies of the different causes of anaemia including absolute and functional iron deficiency, and the association of different haematological parameters, including plasma hepcidin, a key protein responsible for iron regulation, with outcomes after cardiac surgery. METHODS: Prospective observational study between January 2012 and 2013; 200 anaemic cardiac surgical patients were recruited and 165 were studied. Detailed blood and bone marrow analysis was performed. Primary outcome was days alive and out of hospital. RESULTS: Mean (SD) haemoglobin (Hb) was 102 (8) g/L for women and 112 (11) g/L for men. Regarding outcomes, 137 (83%) patients were transfused at least one unit of red blood cells; 30-day mortality was 1.8% (three patients). Functional iron deficiency was diagnosed in 78 patients (47%). Plasma hepcidin concentration was the only haematological variable associated with outcome, with mean days alive and out of hospital 2.7 (95% CI 0.4 to 5.1) days less if hepcidin ≥20 ng/mL compared with <20 ng/mL (p=0.024). Multivariable analysis showed that the association between hepcidin and outcome was independent of risk (European System for Cardiac Operative Risk Evaluation), transfusion and Hb. CONCLUSIONS: Functional iron deficiency was the most common cause of anaemia but was not associated with outcome. The only haematological parameter that was associated with outcome was hepcidin concentration, which is a novel finding and introduces further complexity into our understanding of the role of iron and its regulation by hepcidin. We propose that future research should target patients with elevated hepcidin. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVES: Preoperative anaemia is associated with increased morbidity and mortality. We sought to determine the relative frequencies of the different causes of anaemia including absolute and functional iron deficiency, and the association of different haematological parameters, including plasma hepcidin, a key protein responsible for iron regulation, with outcomes after cardiac surgery. METHODS: Prospective observational study between January 2012 and 2013; 200 anaemic cardiac surgical patients were recruited and 165 were studied. Detailed blood and bone marrow analysis was performed. Primary outcome was days alive and out of hospital. RESULTS: Mean (SD) haemoglobin (Hb) was 102 (8) g/L for women and 112 (11) g/L for men. Regarding outcomes, 137 (83%) patients were transfused at least one unit of red blood cells; 30-day mortality was 1.8% (three patients). Functional iron deficiency was diagnosed in 78 patients (47%). Plasma hepcidin concentration was the only haematological variable associated with outcome, with mean days alive and out of hospital 2.7 (95% CI 0.4 to 5.1) days less if hepcidin ≥20 ng/mL compared with <20 ng/mL (p=0.024). Multivariable analysis showed that the association between hepcidin and outcome was independent of risk (European System for Cardiac Operative Risk Evaluation), transfusion and Hb. CONCLUSIONS: Functional iron deficiency was the most common cause of anaemia but was not associated with outcome. The only haematological parameter that was associated with outcome was hepcidin concentration, which is a novel finding and introduces further complexity into our understanding of the role of iron and its regulation by hepcidin. We propose that future research should target patients with elevated hepcidin. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Nadine Shehata; Nikhil Mistry; Bruno R da Costa; Tiago V Pereira; Richard Whitlock; Gerard F Curley; David A Scott; Gregory M T Hare; Peter Jüni; C David Mazer Journal: Eur Heart J Date: 2019-04-01 Impact factor: 29.983
Authors: Toby Richards; Ravishankar Rao Baikady; Ben Clevenger; Anna Butcher; Sandy Abeysiri; Marisa Chau; Rebecca Swinson; Tim Collier; Matthew Dodd; Laura Van Dyck; Iain Macdougall; Gavin Murphy; John Browne; Andrew Bradbury; Andrew Klein Journal: Health Technol Assess Date: 2021-02 Impact factor: 4.014
Authors: Stephan von Haehling; Ewa A Jankowska; Dirk J van Veldhuisen; Piotr Ponikowski; Stefan D Anker Journal: Nat Rev Cardiol Date: 2015-07-21 Impact factor: 32.419
Authors: Matthew C Frise; David A Holdsworth; Manraj S Sandhu; Adrian J Mellor; Adetayo S Kasim; Helen C Hancock; Rebecca H Maier; Keith L Dorrington; Peter A Robbins; Enoch F Akowuah Journal: J Cardiothorac Surg Date: 2022-06-16 Impact factor: 1.522
Authors: Elio Venturini; Gabriella Iannuzzo; Anna DI Lorenzo; Gianluigi Cuomo; Andrea D'Angelo; Pasquale Merone; Giuseppe Cudemo; Mario Pacileo; Antonello D'Andrea; Carlo Vigorito; Francesco Giallauria Journal: Int J Cardiol Heart Vasc Date: 2022-05-02
Authors: Toby Richards; Ben Clevenger; Jane Keidan; Tim Collier; Andrew A Klein; Stefan D Anker; John D Kelly Journal: Trials Date: 2015-06-04 Impact factor: 2.279